About
David A. Sinclair is an Australian-American geneticist and Harvard Medical School professor best known for research on aging, epigenetics, sirtuins, and NAD biology. He has translated that research into multiple longevity and biotech companies, including Life Biosciences, Immetas, EdenRoc-affiliated ventures, Animal Bioscience, and Tally Health. He is both a prominent scientific voice in longevity and a repeat founder with documented equity exposure from prior exits.
Areas of interest
longevityaging biologyepigeneticsgene therapybiotechdrug discoveryNAD biologysirtuinsconsumer healthbiomarkersnutritionpet healthreproductive healthneurodegenerationinfectious disease genomics